The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
Inside a refugee camp in Chad
Ancient kids’ drawings show life in doomed Pompeii
Remembering the Regina Rifles on D-Day
Are more interest rate cuts coming?
U.K. voters have been through a lot
Having fun without alcohol
Salman Rushdie on the 27 seconds that nearly killed him
This running club is for Black women, by Black women
Which brand of wellness works for you?
The benefits of ‘exercise snacking’
How ‘sense foraging’ can calm a busy mind
Why your approach to back pain could be all wrong
How to have a happy and healthy gut
Tackling air travel problems in Canada
Why the northern lights are heading south — again
Mexico votes in first woman president after bloody election
Voters brave 52 C heat in final days of India’s election
How Trump’s conviction plays out in White House race
Wegovy costs $400 a month. Should provinces pay?
If crows can count, what else can they do?
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly